Categories LATEST

IBM Q3 2024 Earnings Call: Listen Live and Get the Real-Time Transcript

Tech giant International Business Machines Corporation (NYSE: IBM) will publish its third quarter 2024 results today after the closing bell.


Listen to IBM’s Q3 2024 earnings call live and read the real-time transcript


On average, analysts forecast earnings of $2.23 per share for the September quarter, on an adjusted basis, compared to $2.01 per share in the prior-year quarter. Revenues are expected to increase 12% year-over-year to $15.07 billion.

For the second quarter, IBM reported revenues of $15.8 billion, compared to $15.5 billion in the same period last year. Adjusted earnings from continuing operations rose to $2.43 per share in Q2 from $2.18 per share a year earlier.

On an unadjusted basis, net profit was $1.83 billion or $1.96 per share in the second quarter, compared to $1.58 billion or $1.72 per share in the corresponding period last year

Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.

Most Popular

Citigroup set to report Q4 2025 earnings. Here’s what to expect

Citigroup Inc. (NYSE: C) has undergone a sweeping transformation in recent years, emerging as a more streamlined and profitable financial institution. The bank's performance in recent quarters has underscored the

Home Depot (HD), Lowe’s (LOW): Home improvement pressures not expected to abate soon

Home improvement retailers Home Depot (NYSE: HD) and Lowe’s Companies, Inc. (NYSE: LOW) have been facing a challenging operating environment for a while now. The companies have been battling macroeconomic

Earnings Summary: AngioDynamics (ANGO) Q2 FY26 sales increase 8.8%

Medical technology company AngioDynamics, Inc. (NASDAQ: ANGO) on Tuesday reported an increase in net sales for the second quarter of fiscal 2026. In Q2, net sales increased 8.8% year-over-year to

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top